Regeneron Pharmaceuticals (REGN) insider buying
8 open-market purchases of REGN by Regeneron Pharmaceuticals's executives and directors since November 2025, worth $0 in total, from SEC Form 4 filings.
The most recent: Julia Letlow bought — on February 12, 2026.
The biggest buyer over the period is Julia Letlow: 2 purchases, $0.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 4 | $0 |
| 2025 | 4 | $0 |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Julia Letlow | 2 | $0 |
| Ro Khanna | 4 | $0 |
| Gilbert Ray Cisneros, Jr. | 2 | $0 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Feb 12, 2026 | Julia Letlow |
0 | $783.65 | — | — |
| Feb 12, 2026 | Julia Letlow |
0 | $783.65 | — | — |
| Jan 23, 2026 | Ro Khanna |
0 | $753.55 | — | — |
| Jan 23, 2026 | Ro Khanna |
0 | $753.55 | — | — |
| Nov 18, 2025 | Gilbert Ray Cisneros, Jr. |
0 | $725.34 | — | — |
| Nov 18, 2025 | Gilbert Ray Cisneros, Jr. |
0 | $725.34 | — | — |
| Nov 3, 2025 | Ro Khanna |
0 | $642.25 | — | — |
| Nov 3, 2025 | Ro Khanna |
0 | $642.25 | — | — |
Questions
Are Regeneron Pharmaceuticals insiders buying the stock?
8 open-market purchases of REGN by Regeneron Pharmaceuticals's executives and directors since November 2025, worth $0 in total, from SEC Form 4 filings. The most recent: Julia Letlow bought — on February 12, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Regeneron Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.